Oncolytics Share Price
NASDAQ: ONCY | Micro Cap | HealthcareOncolytics Stock Performance
Oncolytics Share Price Today
As of 21 November 2026, Oncolytics Biotech, Inc.'s share price is $0.35. The stock opened at $0.38, compared to its previous close of $0.39. During today's trading session, Oncolytics Biotech, Inc.'s share price traded between $0.34 and $0.38, with an average price of $0.36. Over the past 52 weeks, the stock has recorded a high of $1.30 and a low of $0.34. In terms of performance, Oncolytics Biotech, Inc.'s share price has declined by 66.57% over the last six months and is down 64.55% on a year-on-year basis.
Oncolytics Share Price Chart
Oncolytics Quarterly Profit & Loss
All figures in USD
Oncolytics Annual Profit & Loss
All figures in USD
Oncolytics Balance Sheet
All figures in USD Million
Oncolytics Cash Flow
All figures in USD Million
About Oncolytics
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Oncolytics Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.42 | $0.35 | -18.18% |
Oct 2026 | $0.63 | $0.43 | -35.20% |
Sep 2026 | $0.83 | $0.66 | -22.21% |
Aug 2026 | $0.75 | $0.85 | +14.08% |
Jul 2026 | $0.93 | $0.75 | -20.97% |
Jun 2026 | $1.16 | $0.94 | -10.10% |
May 2026 | $0.91 | $1.05 | +17.06% |
Apr 2026 | $0.85 | $0.90 | +5.16% |
Mar 2026 | $1.11 | $0.85 | -24.18% |
Feb 2026 | $0.98 | $1.13 | +14.21% |
Jan 2026 | $0.91 | $0.98 | +13.87% |
Dec 2025 | $0.99 | $0.86 | -12.63% |